CRISPR-Cas9 is significantly potential and versatile gene-editing treatment for neurodegenerative disorders. The CRISPR-Cas9 system incorporates a single guide RNA (sgRNA) and Cas9 nuclease, which helps system to bind to the target sequence, and makes a double-strand break respectively. Viral vectors, as traditional delivery system of CRISPR-Cas9, cause safety issue regrading immunogenic complications. In this work we present alternative non-viral vectors with plasmonic properties as a delivery system. Our work provides a new perspective of nanoparticles for delivery and visualization applications of the CRISPR-Cas9 system.